Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of America Corp (BAC) vs BIO-TECHNE Corp (TECH) Price & Performance

Bank of America CorpTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

Bank of America Corp vs BIO-TECHNE Corp — how do they compare? Bank of America Corp trades at $60.62 (market cap $422.25B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Bank of America Corp is far larger — about 38× BIO-TECHNE Corp's market cap, and Bank of America Corp pays the higher dividend (1.88%). Which is the better fit depends on your goals.

BACTECH
Market Cap
$422.25B$11.12B
Volume
55,637,172
Sector
FinancialsHealth
52-Week High
$60.62$71.38
52-Week Low
$44.92$43.31
Dividend Yield
1.88%0.45%
Enterprise Value
$11.20B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bank of America Corp

Bank of America (BAC) trades at $60.62, up 1.59% today, with a bullish technical signal from moving averages and a consensus analyst price target of $63.79. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.11 exceeding expectations. Revenue grew to $113.10 billion in 2025, and the company maintains a strong deposit franchise, as highlighted by recent news coverage.

The outlook is positive, supported by earnings momentum and potential capital returns post-stress tests. Risks include macroeconomic sensitivity and regulatory changes. Analyst sentiment is strongly bullish, with 65% recommending Buy.

BIO-TECHNE Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bank of America Corp

Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.

Read more on BAC

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH